Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS

OBJECTIVE: In an ongoing, open-label, phase 1b study on the intrathecal administration of rituximab for progressive multiple sclerosis, an intraventricular catheter was inserted for drug delivery. The objective of this study was to characterize the limited white matter axonal injury evoked by cathet...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neurol Neuroimmunol Neuroinflamm
Päätekijät: Bergman, Joakim, Dring, Ann, Zetterberg, Henrik, Blennow, Kaj, Norgren, Niklas, Gilthorpe, Jonathan, Bergenheim, Tommy, Svenningsson, Anders
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lippincott Williams & Wilkins 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4972001/
https://ncbi.nlm.nih.gov/pubmed/27536708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000271
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia